Stocksigma LogoStocksigma Logo

Natco Pharma Board Approves ₹1,279.36 Crore Rights Issue

Natco Pharma's board approved a Rights Issue to raise up to ₹1,279.36 crore through the issuance of 1,70,58,082 equity shares of face value ₹2 each at ₹750

Natco Pharma Board Approves ₹1,279.36 Crore Rights Issue

Natco Pharma Ltd · Others (Uncategorized) · 25 Sept 2026, 4:49 pm

Natco Pharma Board Approves ₹1,279.36 Crore Rights Issue Natco Pharma's board approved a Rights Issue to raise up to ₹1,279.36 crore through the issuance of 1,70,58,082 equity shares of face value ₹2 each at ₹750 per share (including a ₹748 premium). The entitlement ratio is set at 2 rights shares for every 21 shares held as of the record date on 1st Oct'26. The issue opens on 12th Oct'26 and closes on 22nd Oct'26, with on-market renunciation from 12th Oct'26 to 16th Oct'26. Outstanding equity shares will expand from 17,91,09,870 to 19,61,67,952 post-issue.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements